Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study.

Translated title of the contribution: Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study.
  • M.F. Bakker
  • , J.W.G. Jacobs
  • , P.M.J. Welsing
  • , J.H. van der Werf
  • , S.P. Linn-Rasker
  • , M.J. van der Veen
  • , F.P.J.G. Lafeber
  • , J.W.J. Bijlsma

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionAre switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study.
Original languageUndefined/Unknown
Pages (from-to)1849-1852
Number of pages4
JournalAnnals of the Rheumatic Diseases
Volume69
Issue number10
Publication statusPublished - 2010

Cite this